Publications by authors named "William G Martin"

Article Synopsis
  • A phase 2 clinical trial tested the cyclin-dependent kinase inhibitor SCH 727965 in patients with metastatic melanoma to assess its safety and effectiveness, focusing on overall survival and progression-free survival rates.* -
  • Among 72 enrolled patients, there were no observed responses to the treatment out of 67 evaluable cases, with stable disease in only 21%, median progression-free survival at 1.4 months, and median overall survival at 8.2 months.* -
  • Despite some patients achieving a 1-year overall survival rate of 38%, the study concluded that SCH 727965 showed minimal benefit and significant toxic effects, suggesting it should not be further pursued as a single-agent therapy.*
View Article and Find Full Text PDF

Background: Vessel sizing and calcium detection by intracoronary imaging informs optimal strategy during coronary interventions, but image interpretation and analysis software vary considerably between platforms. We compared the interobserver variability of clinicians with a range of experience in assessing co-registered optical coherence tomography (OCT) and 20 MHz solid state intravascular ultrasound (IVUS) vessel/ lumen geometry and quantitative plaque data.

Methods: Co-registered OCT and IVUS frames at the minimum lumen area (MLA) and 5 frames at 2 mm intervals upstream and downstream were read blinded by an expert, consultant, interventional fellow and registrar to define vessel and lumen sizes, plaque characteristics (arc of calcium and lipid) and presence of OCT-defined thin-capped fibroatheroma (TCFA).

View Article and Find Full Text PDF

Idiopathic granulomatous hypophysitis (IGH) is a rare inflammatory disease of the pituitary. There is debate in the scientific literature as to whether IGH represents a continuum of disease with lymphocytic hypophysitis or has a distinct pathogenesis. Due to the rare nature of the disease, previous descriptions have been limited to single case reports or small series.

View Article and Find Full Text PDF

Purpose: Bleomycin pulmonary toxicity (BPT) has been well described in Hodgkin's lymphoma (HL) patients treated with bleomycin-containing chemotherapy regimens. The influence of this pulmonary complication, along with the omission of bleomycin from further chemotherapy, on overall survival (OS) and progression-free survival (PFS) in HL remains unclear. We reviewed our experience with BPT in HL to better delineate outcome and appropriate treatment in these patients.

View Article and Find Full Text PDF